Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation

Eliem Therapeutics, Inc. (ELYM) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/21/2023 3 Pimblett Emily (Chief Accounting Officer) has filed a Form 3 on Eliem Therapeutics, Inc.
03/14/2023 4 Morisset Valerie (EVP, R&D and CSO) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Exercised 255,219 options to buy @ $0.002, valued at $510.4
Exercised 61,191 options to buy @ $0.0002, valued at $12.2
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2022 4 Tate Simon (Director) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.46, valued at $34.6k
06/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2022 4 Rosenberg Adam Joseph (Director) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.46, valued at $34.6k
06/01/2022 4 Levin Andrew David (Director) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.46, valued at $34.6k
06/01/2022 4 Dunn Judith (Director) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.46, valued at $34.6k
01/31/2022 4 Lavelle Erin (COO & CFO) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 170,000 options to buy @ $8.21, valued at $1.4M
01/31/2022 4 Azelby Robert (President & CEO) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 500,000 options to buy @ $8.21, valued at $4.1M
01/31/2022 4 Morisset Valerie (EVP, R&D and CSO) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 170,000 options to buy @ $8.21, valued at $1.4M
01/31/2022 4 Bucher James B (EVP and General Counsel) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 95,000 options to buy @ $8.21, valued at $780k
08/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2021 4 Rosenberg Adam Joseph (Director) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $12.5, valued at $250k
08/11/2021 4 Tate Simon (Director) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $12.5, valued at $250k
08/11/2021 4 Levin Andrew David (Director) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $12.5, valued at $250k
08/09/2021 3 AI ETI LLC (10% Owner) has filed a Form 3 on Eliem Therapeutics, Inc.
08/09/2021 3 Dunn Judith (Director) has filed a Form 3 on Eliem Therapeutics, Inc.
08/09/2021 3 PATTERSON LEONE D (Director) has filed a Form 3 on Eliem Therapeutics, Inc.
08/09/2021 3 Ratcliffe Liam (Director) has filed a Form 3 on Eliem Therapeutics, Inc.
08/09/2021 3 Rosenberg Adam Joseph (Director) has filed a Form 3 on Eliem Therapeutics, Inc.
08/09/2021 3 Tate Simon (Director) has filed a Form 3 on Eliem Therapeutics, Inc.
08/09/2021 3 RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 3 on Eliem Therapeutics, Inc.
08/09/2021 3 Levin Andrew David (Director) has filed a Form 3 on Eliem Therapeutics, Inc.
08/09/2021 3 Bucher James B (EVP and General Counsel) has filed a Form 3 on Eliem Therapeutics, Inc.
08/09/2021 3 Lavelle Erin (COO & CFO) has filed a Form 3 on Eliem Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy